Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) [Yahoo! Finance]
Benitec Biopharma Inc. (NASDAQ: BNTC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $30.00 price target on the stock.